Atom Investors’s Praxis Precision Medicines PRAX Stock Holding History

Atom Investors’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.63M	Sell	7,859 -13,337	-63%	-$4.22M	0.23%	110
2026 Q1	$6.83M	Buy	21,196 +4,709	+29%	+$1.46M	0.49%	35
2025 Q4	$4.86M	Buy	+16,487	New	+$3.07M	0.39%	70
2025 Q2	–	Sell	-19,779	Closed	-$749K	–	749
2025 Q1	$749K	Buy	+19,779	New	+$1.24M	0.09%	247
2024 Q2	–	Sell	-34,867	Closed	-$2.13M	–	625
2024 Q1	$2.13M	Buy	34,867 +4,830	+16%	+$217K	0.27%	121
2023 Q4	$669K	Buy	30,037 +23,185	+338%	+$418K	0.12%	231
2023 Q3	$176K	Buy	+6,852	New	+$130K	0.04%	384
2023 Q1	–	Sell	-1,773	Closed	-$63.3K	–	306
2022 Q4	$63.3K	Buy	+1,773	New	+$55.3K	0.03%	203

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Atom Investors's PRAX Position: Q2 2026 in Review

Atom Investors reduced its Praxis Precision Medicines (PRAX) stake by 63% in Q2 2026, selling an estimated $4.22M and leaving 7,859 shares worth $2.63M. The position accounts for 0.23% of the portfolio, ranked #110.

Atom Investors first reported a position in PRAX in Q4 2022 and has held it in 8 quarters since. The position peaked at $6.83M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Atom Investors held 7,859 shares of Praxis Precision Medicines worth $2.63M as of Q2 2026.
Atom Investors sold 13,337 Praxis Precision Medicines shares in Q2 2026, an estimated $4.22M.
Praxis Precision Medicines made up 0.23% of Atom Investors's portfolio in Q2 2026, its #110 holding.
Atom Investors first reported a position in Praxis Precision Medicines in Q4 2022 and has held it in 8 quarters since.
Atom Investors's Praxis Precision Medicines position peaked at $6.83M in Q1 2026.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.